CLINICAL_TRIALS trial_result · 2013-02-22

Clinical Trial Update: A Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Rotator Cuff Tears [Phase 1]

Pfizer's Phase 1 safety study of BMP-655/ACS as adjuvant therapy for rotator cuff tears has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Rotator Cuff Tear | Phase 1 | Status: TERMINATED